Myocardial Reperfusion Injury Clinical Trial
Official title:
POSTconditioning During Coronary Angioplasty in Acute Myocardial Infarction Study (POST-AMI)
The POST-conditioning during coronary angioplasty in Acute Myocardial Infarction (POST-AMI) trial will evaluate the usefulness of postconditioning in limiting infarct size and microvascular damage during the early and late phases after AMI.
POST-AMI is a single-center, prospective, randomized trial, with a planned inclusion of 78 patients with ST-elevation Acute Myocardial Infarction (AMI). Patients will be randomly assigned to postconditioning arm (primary angioplasty (PA) and stenting followed by brief episodes of ischemia-reperfusion performed during the first minutes of reperfusion) or non-postconditioning arm (PA and stenting without additional intervention). All patients will be treated medically according to current international guidelines, including glycoprotein IIb/IIIa inhibitors before PCI. The primary end point is to evaluate whether postconditioning, compared to PA without additional intervention, reduces infarct size estimated by magnetic resonance at 30±10 days after the AMI. Secondary end points are microvascular obstruction observed at magnetic resonance, ST-segment elevation resolution, persistent ST-segment elevation, angiographic myocardial blush grade <2 and non sustained/sustained ventricular tachycardia in the 48 hours following PA. Further secondary end points are enzymatic infarct size, left ventricular remodeling and left ventricular function at magnetic resonance performed at 6±1 months, and the reduction of major adverse cardiac events at 30 days and 6 months. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00989508 -
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04570514 -
Optimized Cardioprotection Therapy in Obese Subjects With AMI
|
||
Active, not recruiting |
NCT01857414 -
Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI
|
N/A | |
Completed |
NCT02342522 -
Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI)
|
N/A | |
Active, not recruiting |
NCT05462730 -
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
|
Phase 2 | |
Completed |
NCT04397939 -
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
|
||
Withdrawn |
NCT02098629 -
Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction
|
Phase 1/Phase 2 | |
Completed |
NCT00586820 -
Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
|
Phase 2 | |
Completed |
NCT02390674 -
Ciclosporin to Reduce Reperfusion Injury in Primary PCI
|
Phase 2 | |
Completed |
NCT00865722 -
Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)
|
Phase 2/Phase 3 | |
Recruiting |
NCT01307371 -
Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)
|
Phase 1 | |
Completed |
NCT01379261 -
Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction
|
Phase 2/Phase 3 | |
Completed |
NCT00881686 -
Myocardial Protection With Adenosine Preconditioning
|
Phase 1/Phase 2 | |
Completed |
NCT00484575 -
Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting
|
Phase 1/Phase 2 | |
Recruiting |
NCT03995732 -
Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury
|
Phase 2 | |
Recruiting |
NCT05775380 -
The Role of Pioglitazone in Vascular Transcriptional Remodeling
|
Phase 4 | |
Completed |
NCT06450912 -
Wall Strain Index Ratio as a Biomarker for Mechanical Complication of Hemorrhagic Myocardial Infarction
|
||
Completed |
NCT05354648 -
Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients
|
N/A | |
Completed |
NCT01601795 -
Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)
|
Phase 4 | |
Completed |
NCT01354808 -
ACCEL-LOADING-ACS Study
|
Phase 4 |